Similar to nF-MS patients, both relapse-free and relapsed F-MS patients showed significantly lower levels of Foxp3+ Treg compared with HS (p = 0.0095 and p = 0.0012, respectively). Here, FOXP3 is linked to myeloid sarcoma.